Clinical Trial Update: Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of MK-6096 for painful diabetic neuropathy completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Painful Diabetic Neuropathy

Drugs mentioned

• MK-6096

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetic Neuropathy, Painful | Phase 2 | Status: COMPLETED | Results posted: 2016-08-10